human
***TASK*** the task is to summarize an input biomedical literature in six sentences 
    ***INPUT*** the input is a biomedical literature 
    ***OUTPUT*** the output is the summary of an input biomedical literature in six sentences 
    ***DOCUMENTATION*** 
    ***EXAMPLES*** 
    Input: BACKGROUND Iodine deficiency in infants can damage the developing brain and increase mortality . Present recommendations state that oral iodised oil should be given to breastfeeding mothers to correct iodine deficiency in infancy when iodised salt is not available , and that direct supplementation should be given to infants who are not being breastfed or receiving iodine-fortified complimentary foods . However , there is little evidence for these recommendations . We aim ed to assess the safety and efficacy of direct versus indirect supplementation of the infant . METHODS We did this double blind , r and omised , placebo-controlled trial in Morocco . Healthy breastfeeding mothers and their term newborn babies ( aged ≤8 weeks ) were block r and omised by clinic day to receive either : one dose of 400 mg iodine to the mother and placebo to the infant ( indirect infant supplementation ) , or one dose of about 100 mg iodine to the infant and placebo to the mother ( direct infant supplementation ) . R and omisation was masked to participants and investigators . Co primary outcomes were : maternal and infant urinary iodine concentrations , breastmilk iodine concentration , maternal and infant thyroid-stimulating hormone ( TSH ) concentrations , maternal and infant thyroxine ( T4 ) concentrations , and infant growth . These outcomes were measured at baseline , and when infants were aged about 3 months , 6 months , and 9 months , and the two groups were compared using mixed effects models . This study is registered with Clinical Trials.gov , number NCT01126125 . FINDINGS We recruited 241 mother-infant pairs between Feb 25 , and Aug 10 , 2010 , and completed data collection by Aug 6 , 2011 . At baseline , median urinary iodine concentration was 35 μg/L ( IQR 29 - 40 ) in mothers and 73 μg/L ( 29 - 237 ) in infants , suggesting iodine deficiency . During the study , maternal urinary iodine concentration ( p=0.011 ) , breastmilk iodine concentration ( p<0.0001 ) , and infant urinary iodine concentration ( p=0.042 ) were higher in the indirect infant supplementation group than in the direct supplementation group . Maternal TSH ( p=0.276 ) and T4 ( p=0.074 ) concentrations did not differ between the groups over the course of the study , nor did infant TSH ( p=0.597 ) and T4 ( p=0.184 ) concentrations , but the number of infants with thyroid hypofunction was lower ( p=0.023 ) in the indirect supplementation group than the direct supplementation group . The infant groups did not differ in anthropomorphic measures , except that length-for-age Z score was slightly greater in the direct infant supplementation group ( p=0.032 ) . At 3 months and 6 months of age , median infant urinary iodine concentration in the indirect infant supplementation group was sufficient ( > 100 μg/L ) , whereas infant urinary iodine concentration was sufficient only at 6 months in the direct supplementation group . There were no serious adverse events in either group . INTERPRETATION In regions of moderate-to-severe iodine deficiency without effective salt iodisation , lactating women who receive one dose of 400 mg iodine as oral iodised oil soon after delivery can provide adequate iodine to their infants through breastmilk for at least 6 months , enabling the infants to achieve euthyroidism . Direct supplementation is less effective in improving infant iodine status . FUNDING ETH Zurich , Switzerl and ; the Medicor Foundation , Vaduz , Lichtenstein Adequate iodine concentration in breastmilk ( BMI C ) is essential for optimal neonatal thyroid hormone synthesis and neurological development in breastfed infants . For many decades , iodine deficiency has been a public health problem in Nepal . However , recently , excessive iodine intakes among Nepali infants have been reported . This study aim ed to measure BMI C and urinary iodine concentration ( UIC ) among lactating women in a peri-urban area of Nepal .  Iodine concentration was measured in spot urine ( n = 485 ) and breastmilk sample s ( n = 291 ) of 500 r and omly selected lactating women . The median ( p25 , p75 ) BMI C and median UIC were 250 ( 130 , 370 ) µg/L and 230 ( 135–377 ) µg/L , respectively . Around 82 % had BMI C > 100 µg/L , 61 % had BMI C > 200 µg/L and 81 % had UIC > 100 µg/L , 37 % had > 300 µg/L and 20 % had > 500 µg/L. In multiple linear regression models , time since birth ( β 3.0 , 95 % CI ( 0.2 , 5.0 ) ) and UIC ( β 1.0 , 95 % CI ( 0.1 , 2.0 ) ) were associated with BMI C , explaining 26 % of the variance . A large proportion of the women had adequate BMI C and UIC ; however , a subset had high iodine concentrations . These findings emphasize the importance of carefully monitoring iodine intake to minimize the risk of iodine excess and subsequently preventing transient iodine-induced hypothyroidism in breastfed infants BACKGROUND Iodine deficiency in infancy can impair neurocognitive development , but there are few available indicators of iodine intake during this critical period . In many countries , access to newborns in maternity clinics in the first few days after birth is high . If spot urine sample s could be collected , reference data for urinary iodine concentration ( UIC ) would be useful to evaluate their iodine status . The study objectives were 1 ) to develop and vali date a simple pad system for collection of spot urine sample s for iodine ; 2 ) to establish a reference range for UIC in newborns in the first week after birth for use in monitoring iodine nutrition . METHODS A two-stage cluster sampling was used to obtain a representative national sample of healthy , term Swiss infants , 0 to 5 days old ( n = 634 ) .  Gestational information , whole blood for thyrotropin , and spot urine sample s on two consecutive days were collected . RESULTS The pad collection system was well-accepted and performed well during recovery and contamination testing . Median UIC in the total sample ( n = 1224 ) was 77 ( 95 % confidence interval ; 76 , 81 ) microg/L ; there was a gradual increase in median UIC within the range of 70 - 100 microg/L from days 1 through 4 . Because urinary creatinine concentrations were high and variable , the UI : creatinine ratio was not useful for st and ardization . CONCLUSIONS The current WHO median UIC cut-off ( > 100 microg/L ) for iodine sufficiency in infancy may be too high for the first week after birth . Reference data from iodine-sufficient newborns and a simple collection system may facilitate use of UIC as an indicator of iodine status in this age group OBJECTIVE To assess the iodine nutrition and thyroid function of pregnant women , lactating women and infants residing in areas where the Universal Salt Iodization program is in place . METHODS Pregnant women , lactating women and infants were selected r and omly in the regions where iodized salt coverage rate is more than 90 % since 2000 .  Urine iodine levels of pregnant woman , lactating woman and infants , milk iodine of lactating woman , thyroid-stimulating hormone ( TSH ) and free T4 of women were tested respectively . RESULTS Median Urinary Iodine ( MUI ) of infants , three groups of pregnant women ( first , second and third trimester ) and two groups lactating women ( breastfeeding less than or more than six months ) were 233 , 174 , 180 , 147 , 126 and 145 microg/L , respectively . Median milk iodine of lactating women was 163 microg/L. Percentage of milk iodine < 150 microg/L of early lactating women was 40 % less than that of late lactating women ( p < 0.01).There was a positive correlation between urine iodine of infants and milk iodine of lactating women ( r = 0.526 , p = 0.000 ) . T4 of two women were above or below the reference range . Total 15.4 % women 's TSH were abnormal . Most of these women 's urinary iodine were lower than 150 microg/L. CONCLUSION Iodine status of most of the target population for Universal Salt Iodization program is adequate , but iodine deficiency still existed in some . To assure every new life 's brain not be damaged by iodine deficiency , iodine status of targeted population s should be monitored and supplements provided according to the monitoring outcomes Summary The spontaneous development of thyroid gl and volume ( TGV ) during the first 3 months of life was studied in entirely breast-fed infants ( n = 21 ) and compared to those fed an iodine-supplemented formula ( n = 19 ) , an iodine-free formula ( n = 5 ) , or partially breast-fed in addition to an iodine-free ( n = 4 ) or an iodine-supplemented formula ( n = 16 ) . The TGV of the infants and their mothers was determined sonographically in addition to their urinary iodine concentrations 57 days postpartum and 3 months later . In ten additional lactating mothers the breast milk concentrations of thyroid hormones and iodine were determined . It was shown that at 3 months of age an infant consuming about 1000 ml breast milk per day receives about 2 μg thyroid hormones and 55 μg iodine per day . At the end of their first week of life the infants showed a TGV between 0.28 and 1.5 ml ( median 0.61 ml ) and a urinary iodine concentration between 0.03 and 16.3 μg/dl ( median 3.0 μg/dl ) . At 3 months of age the TGV of the breast-fed infants had decreased by a median of 0.24 ml (= −34 % ; median of percentage changes ) whereas those fed a formula without iodine had increased by a median of 0.26 ml (= + 50 % ; median of percentage changes ) . Those receiving an iodine-supplemented formula  showed a TGV reduction of 0.14 ml (= + 2 % ; median of percentage changes ) . The TGV development of the partially breast-fed infants lay between those being exclusively breast or formula fed . It is concluded that with respect to the development of TGV , breast milk is superior even to the feeding of an iodine-supplemented formula Abstract . Belgium used to be affected by mild iodine deficiency . Improvement in iodine nutrition has been recently documented in schoolchildren in Belgium in spite of the absence of any systematic programme of iodine supplementation . The question arises as to whether this ' silent iodine prophylaxis ' affected also the neonates . A total of 185 r and om urine sample s were collected from 90 full term and 65 preterm neonates in Brussels on day 5 and repeated on day 30 in 30 preterms who were bottle-fed with iodine-enriched formula-milk . The iodine content was also determined in 58 sample s of breast-milk on day 5 . The median urinary iodine on day 5 in full term neonates was 86 µg/l , which is markedly higher than the figure of 48 µg/L reported 15 years previously in neonates in the same area but still much lower than normal for this age group ( 150–200 µg/l ) . The mean iodine content of breast-milk was 78 µg/l , which is unchanged as compared to 15 years ago and is about 66 % of normal . Finally , the median urinary iodine increased from 60 µg/l on day 5 to 150 µg/l on day 30 in preterms bottle-fed with iodine-enriched formula-milk . Conclusion : the status of iodine nutrition has also improved spontaneously in Belgian neonates but has not yet normalised . Lactating and probably pregnant women remain clearly iodine deficient . The iodine-enriched formula-milk for preterms is efficient in correcting their iodine deficiency . National measures are urgently required for correction of iodine deficiency in Belgium BACKGROUND Little is known about the iodine status of lactating mothers and their infants during the first 6 mo postpartum or , if deficient , the amount of supplemental iodine required to improve status . OBJECTIVE The objective was to determine maternal and infant iodine status and the breast-milk iodine concentration ( BMI C ) over the first 6 mo of breastfeeding . DESIGN A r and omized , double-blind , placebo-controlled supplementation trial was conducted in lactating women who received placebo ( n = 56 ) , 75 μg I/d ( n = 27 ) , or 150 μg I/d ( n = 26 ) after their infants ' birth until 24 wk postpartum .  Maternal and infant urine sample s and breast-milk sample s 
    Output:
    
agent
The results are thus compatible with the international recommendation that lactating women and infants younger than two years of age who reside in iodine-sufficient countries do not require iodine supplementation
***TASK*** the task is to summarize an input biomedical literature in six sentences 
    ***INPUT*** the input is a biomedical literature 
    ***OUTPUT*** the output is the summary of an input biomedical literature in six sentences 
    ***DOCUMENTATION*** 
    ***EXAMPLES*** 
    Input: BACKGROUND Iodine deficiency in infants can damage the developing brain and increase mortality . Present recommendations state that oral iodised oil should be given to breastfeeding mothers to correct iodine deficiency in infancy when iodised salt is not available , and that direct supplementation should be given to infants who are not being breastfed or receiving iodine-fortified complimentary foods . However , there is little evidence for these recommendations . We aim ed to assess the safety and efficacy of direct versus indirect supplementation of the infant . METHODS We did this double blind , r and omised , placebo-controlled trial in Morocco . Healthy breastfeeding mothers and their term newborn babies ( aged ≤8 weeks ) were block r and omised by clinic day to receive either : one dose of 400 mg iodine to the mother and placebo to the infant ( indirect infant supplementation ) , or one dose of about 100 mg iodine to the infant and placebo to the mother ( direct infant supplementation ) . R and omisation was masked to participants and investigators . Co primary outcomes were : maternal and infant urinary iodine concentrations , breastmilk iodine concentration , maternal and infant thyroid-stimulating hormone ( TSH ) concentrations , maternal and infant thyroxine ( T4 ) concentrations , and infant growth . These outcomes were measured at baseline , and when infants were aged about 3 months , 6 months , and 9 months , and the two groups were compared using mixed effects models . This study is registered with Clinical Trials.gov , number NCT01126125 . FINDINGS We recruited 241 mother-infant pairs between Feb 25 , and Aug 10 , 2010 , and completed data collection by Aug 6 , 2011 . At baseline , median urinary iodine concentration was 35 μg/L ( IQR 29 - 40 ) in mothers and 73 μg/L ( 29 - 237 ) in infants , suggesting iodine deficiency . During the study , maternal urinary iodine concentration ( p=0.011 ) , breastmilk iodine concentration ( p<0.0001 ) , and infant urinary iodine concentration ( p=0.042 ) were higher in the indirect infant supplementation group than in the direct supplementation group . Maternal TSH ( p=0.276 ) and T4 ( p=0.074 ) concentrations did not differ between the groups over the course of the study , nor did infant TSH ( p=0.597 ) and T4 ( p=0.184 ) concentrations , but the number of infants with thyroid hypofunction was lower ( p=0.023 ) in the indirect supplementation group than the direct supplementation group . The infant groups did not differ in anthropomorphic measures , except that length-for-age Z score was slightly greater in the direct infant supplementation group ( p=0.032 ) . At 3 months and 6 months of age , median infant urinary iodine concentration in the indirect infant supplementation group was sufficient ( > 100 μg/L ) , whereas infant urinary iodine concentration was sufficient only at 6 months in the direct supplementation group . There were no serious adverse events in either group . INTERPRETATION In regions of moderate-to-severe iodine deficiency without effective salt iodisation , lactating women who receive one dose of 400 mg iodine as oral iodised oil soon after delivery can provide adequate iodine to their infants through breastmilk for at least 6 months , enabling the infants to achieve euthyroidism . Direct supplementation is less effective in improving infant iodine status . FUNDING ETH Zurich , Switzerl and ; the Medicor Foundation , Vaduz , Lichtenstein Adequate iodine concentration in breastmilk ( BMI C ) is essential for optimal neonatal thyroid hormone synthesis and neurological development in breastfed infants . For many decades , iodine deficiency has been a public health problem in Nepal . However , recently , excessive iodine intakes among Nepali infants have been reported . This study aim ed to measure BMI C and urinary iodine concentration ( UIC ) among lactating women in a peri-urban area of Nepal .  Iodine concentration was measured in spot urine ( n = 485 ) and breastmilk sample s ( n = 291 ) of 500 r and omly selected lactating women . The median ( p25 , p75 ) BMI C and median UIC were 250 ( 130 , 370 ) µg/L and 230 ( 135–377 ) µg/L , respectively . Around 82 % had BMI C > 100 µg/L , 61 % had BMI C > 200 µg/L and 81 % had UIC > 100 µg/L , 37 % had > 300 µg/L and 20 % had > 500 µg/L. In multiple linear regression models , time since birth ( β 3.0 , 95 % CI ( 0.2 , 5.0 ) ) and UIC ( β 1.0 , 95 % CI ( 0.1 , 2.0 ) ) were associated with BMI C , explaining 26 % of the variance . A large proportion of the women had adequate BMI C and UIC ; however , a subset had high iodine concentrations . These findings emphasize the importance of carefully monitoring iodine intake to minimize the risk of iodine excess and subsequently preventing transient iodine-induced hypothyroidism in breastfed infants BACKGROUND Iodine deficiency in infancy can impair neurocognitive development , but there are few available indicators of iodine intake during this critical period . In many countries , access to newborns in maternity clinics in the first few days after birth is high . If spot urine sample s could be collected , reference data for urinary iodine concentration ( UIC ) would be useful to evaluate their iodine status . The study objectives were 1 ) to develop and vali date a simple pad system for collection of spot urine sample s for iodine ; 2 ) to establish a reference range for UIC in newborns in the first week after birth for use in monitoring iodine nutrition . METHODS A two-stage cluster sampling was used to obtain a representative national sample of healthy , term Swiss infants , 0 to 5 days old ( n = 634 ) .  Gestational information , whole blood for thyrotropin , and spot urine sample s on two consecutive days were collected . RESULTS The pad collection system was well-accepted and performed well during recovery and contamination testing . Median UIC in the total sample ( n = 1224 ) was 77 ( 95 % confidence interval ; 76 , 81 ) microg/L ; there was a gradual increase in median UIC within the range of 70 - 100 microg/L from days 1 through 4 . Because urinary creatinine concentrations were high and variable , the UI : creatinine ratio was not useful for st and ardization . CONCLUSIONS The current WHO median UIC cut-off ( > 100 microg/L ) for iodine sufficiency in infancy may be too high for the first week after birth . Reference data from iodine-sufficient newborns and a simple collection system may facilitate use of UIC as an indicator of iodine status in this age group OBJECTIVE To assess the iodine nutrition and thyroid function of pregnant women , lactating women and infants residing in areas where the Universal Salt Iodization program is in place . METHODS Pregnant women , lactating women and infants were selected r and omly in the regions where iodized salt coverage rate is more than 90 % since 2000 .  Urine iodine levels of pregnant woman , lactating woman and infants , milk iodine of lactating woman , thyroid-stimulating hormone ( TSH ) and free T4 of women were tested respectively . RESULTS Median Urinary Iodine ( MUI ) of infants , three groups of pregnant women ( first , second and third trimester ) and two groups lactating women ( breastfeeding less than or more than six months ) were 233 , 174 , 180 , 147 , 126 and 145 microg/L , respectively . Median milk iodine of lactating women was 163 microg/L. Percentage of milk iodine < 150 microg/L of early lactating women was 40 % less than that of late lactating women ( p < 0.01).There was a positive correlation between urine iodine of infants and milk iodine of lactating women ( r = 0.526 , p = 0.000 ) . T4 of two women were above or below the reference range . Total 15.4 % women 's TSH were abnormal . Most of these women 's urinary iodine were lower than 150 microg/L. CONCLUSION Iodine status of most of the target population for Universal Salt Iodization program is adequate , but iodine deficiency still existed in some . To assure every new life 's brain not be damaged by iodine deficiency , iodine status of targeted population s should be monitored and supplements provided according to the monitoring outcomes Summary The spontaneous development of thyroid gl and volume ( TGV ) during the first 3 months of life was studied in entirely breast-fed infants ( n = 21 ) and compared to those fed an iodine-supplemented formula ( n = 19 ) , an iodine-free formula ( n = 5 ) , or partially breast-fed in addition to an iodine-free ( n = 4 ) or an iodine-supplemented formula ( n = 16 ) . The TGV of the infants and their mothers was determined sonographically in addition to their urinary iodine concentrations 57 days postpartum and 3 months later . In ten additional lactating mothers the breast milk concentrations of thyroid hormones and iodine were determined . It was shown that at 3 months of age an infant consuming about 1000 ml breast milk per day receives about 2 μg thyroid hormones and 55 μg iodine per day . At the end of their first week of life the infants showed a TGV between 0.28 and 1.5 ml ( median 0.61 ml ) and a urinary iodine concentration between 0.03 and 16.3 μg/dl ( median 3.0 μg/dl ) . At 3 months of age the TGV of the breast-fed infants had decreased by a median of 0.24 ml (= −34 % ; median of percentage changes ) whereas those fed a formula without iodine had increased by a median of 0.26 ml (= + 50 % ; median of percentage changes ) . Those receiving an iodine-supplemented formula  showed a TGV reduction of 0.14 ml (= + 2 % ; median of percentage changes ) . The TGV development of the partially breast-fed infants lay between those being exclusively breast or formula fed . It is concluded that with respect to the development of TGV , breast milk is superior even to the feeding of an iodine-supplemented formula Abstract . Belgium used to be affected by mild iodine deficiency . Improvement in iodine nutrition has been recently documented in schoolchildren in Belgium in spite of the absence of any systematic programme of iodine supplementation . The question arises as to whether this ' silent iodine prophylaxis ' affected also the neonates . A total of 185 r and om urine sample s were collected from 90 full term and 65 preterm neonates in Brussels on day 5 and repeated on day 30 in 30 preterms who were bottle-fed with iodine-enriched formula-milk . The iodine content was also determined in 58 sample s of breast-milk on day 5 . The median urinary iodine on day 5 in full term neonates was 86 µg/l , which is markedly higher than the figure of 48 µg/L reported 15 years previously in neonates in the same area but still much lower than normal for this age group ( 150–200 µg/l ) . The mean iodine content of breast-milk was 78 µg/l , which is unchanged as compared to 15 years ago and is about 66 % of normal . Finally , the median urinary iodine increased from 60 µg/l on day 5 to 150 µg/l on day 30 in preterms bottle-fed with iodine-enriched formula-milk . Conclusion : the status of iodine nutrition has also improved spontaneously in Belgian neonates but has not yet normalised . Lactating and probably pregnant women remain clearly iodine deficient . The iodine-enriched formula-milk for preterms is efficient in correcting their iodine deficiency . National measures are urgently required for correction of iodine deficiency in Belgium BACKGROUND Little is known about the iodine status of lactating mothers and their infants during the first 6 mo postpartum or , if deficient , the amount of supplemental iodine required to improve status . OBJECTIVE The objective was to determine maternal and infant iodine status and the breast-milk iodine concentration ( BMI C ) over the first 6 mo of breastfeeding . DESIGN A r and omized , double-blind , placebo-controlled supplementation trial was conducted in lactating women who received placebo ( n = 56 ) , 75 μg I/d ( n = 27 ) , or 150 μg I/d ( n = 26 ) after their infants ' birth until 24 wk postpartum .  Maternal and infant urine sample s and breast-milk sample s 
    Output:
    